China’s official pandemic death toll stands at roughly 121,000, but independent research consistently points to a far larger figure. Multiple peer-reviewed studies and leaked administrative data converge on an estimate of roughly 1 to 2 million excess deaths in the months after China abruptly dropped its zero-COVID policy in December 2022 alone, with some analyses suggesting the true cumulative toll across the entire pandemic could be several times higher. The gap between the official count and these independent estimates is one of the most consequential data disputes in modern public health.
What the Official Numbers Say
For most of the pandemic, China reported remarkably few COVID deaths. Through three years of strict lockdowns, mass testing, and quarantine enforcement, the cumulative official death toll remained in the low thousands for a country of 1.4 billion people. Even during the initial 2020 outbreak in Wuhan, official figures placed the city’s COVID death count at around 3,900. But a study using nationwide mortality registry data found that Wuhan actually experienced about 5,954 excess deaths during the first three months of the outbreak, with 4,573 of those classified as pneumonia deaths. Excess mortality risk was more than three times higher in the city’s central districts than in its suburbs.1PubMed. Excess mortality in Wuhan city and other parts of China during the three months of the covid-19 outbreak: findings from nationwide mortality registries
After China abandoned zero-COVID in late 2022, authorities initially acknowledged a sharp rise in deaths but reported a revised total that international observers found implausibly low. The Chinese Center for Disease Control reported roughly 83,000 to 90,000 COVID-related deaths from the exit wave through early 2023. Those figures quickly drew scrutiny from epidemiologists, who noted they were an order of magnitude below what mathematical models predicted for a wave of that scale and speed.
What Happened When Zero-COVID Ended
The speed of China’s exit wave was essentially unprecedented. After three years of near-total suppression, the government dismantled its testing, contact tracing, and quarantine infrastructure within days in early December 2022. Because the population had almost no natural immunity from prior infection, the virus ripped through the country at a pace rarely seen elsewhere. A Bayesian analysis estimated that the nationwide cumulative infection rate reached about 88% by mid-February 2023, with 84% of the entire population infected within a single month of full policy relaxation.2PubMed Central. China’s post-zero-COVID Omicron wave: A Bayesian analysis A cross-sectional survey in Sichuan province found a prevalence rate of about 74% among participants surveyed in the first week of January 2023.3PubMed Central. Epidemiological features of SARS-CoV-2 Omicron infection under new control strategy: a cross-sectional study of the outbreak since December 2022 in Sichuan, China
To put that in perspective, most countries experienced their Omicron waves over weeks to months, with populations that had some combination of prior infection and mRNA vaccination to blunt severity. China compressed its entire first meaningful encounter with the virus into about 30 days, with inactivated-virus vaccines that were less effective against Omicron and with a large elderly population that had not been adequately boosted.
How Researchers Estimated the Real Death Toll
Because China did not release granular, real-time mortality data, researchers turned to a range of indirect methods to estimate how many people actually died. The estimates cluster between roughly 1 and 2 million excess deaths from the exit wave, though the uncertainty ranges are wide.
A study published in JAMA Network Open used provincial-level death registration data and estimated about 1.87 million excess deaths among adults 30 and older during December 2022 and January 2023. The confidence interval ranged from 710,000 to 4.43 million. Statistically significant mortality increases appeared in every province except Tibet, with the largest jumps in less-developed western provinces.4JAMA Network Open. Excess All-Cause Mortality in China After Ending the Zero COVID Policy A separate analysis using deaths of prominent public figures as a proxy for national trends found that weekly mortality among these individuals rose five- to tenfold in the weeks after reopening, implying at least 1.44 million excess deaths.5Journal of Population Economics. Social elites as sentinels: estimating national excess mortality of China’s sudden COVID-19 reopening
A systematic review pulling together multiple studies found that analyses using indirect methods converged on a national excess mortality range of 710,000 to 1.87 million for the exit wave period. Two studies that examined death records in specific districts of Shanghai estimated local excess mortality rates of roughly 154% and 174% above baseline during the surge.6PubMed Central. Excess mortality in Mainland China after the end of the Zero COVID policy: A systematic review Another analysis that used separate crude estimates reached a figure of about 1.35 million excess deaths in December 2022 through January 2023, consistent with the broader range.7PubMed Central. Excess deaths in China during SARS-CoV-2 viral waves in 2022–2023
Not all models reached the same ballpark. One study used infection fatality rate data from Hong Kong and South Korea and projected total COVID deaths through summer 2023 at between roughly 153,000 and 249,000 in a central scenario, with a maximum range stretching to about 691,000 depending on how many non-elderly people were infected and how well the elderly were protected.8PubMed Central. Estimates of COVID-19 deaths in Mainland China after abandoning zero COVID policy That estimate is notably lower than the excess-mortality studies, likely because it counted only deaths directly attributable to COVID infection rather than all excess mortality, which also captures indirect deaths from overwhelmed hospitals and delayed care.
The Cremation Data That Leaked
One of the most striking pieces of evidence came not from a model but from administrative records that briefly surfaced before being pulled down. Cremation figures from Zhejiang province, a relatively wealthy eastern region where over 99% of deaths end in cremation, showed that just under 171,000 cremations occurred in the first quarter of 2023. That compared with about 99,000 in the same quarter of 2022 and 90,000 in 2021, a jump of roughly 72%. Extrapolated across China’s full population, this implied about 1.5 million excess deaths in the first quarter of 2023 alone, closely matching the range predicted by epidemiological models.9PubMed. Covid-19: Leaked cremation data hint at true scale of China’s death rate
Researchers also tried digital surveillance methods, constructing indices from online search volume for terms like “wreath,” “obituary,” “cremation,” and “pass away” to track mortality signals in real time.10Scientific Reports. Inferring China’s excess mortality during the COVID-19 pandemic using online mourning and funeral search volume These approaches have obvious limitations, but they added another independent data stream pointing in the same direction as the cremation records and the statistical models. When three very different methods all converge on the same order of magnitude, the signal becomes harder to dismiss.
Why the Estimates Vary
The range from roughly 700,000 to nearly 2 million deaths for the exit wave is wide, and it reflects genuine uncertainty rather than sloppy methods. Several factors drive the spread. First, China’s death registration system is incomplete and uneven. A study of registration completeness across nearly 2,900 counties found that coverage was substantially better in wealthier eastern regions than in poorer, more rural western ones, with significant variation even within individual provinces.11PubMed Central. Measuring the completeness of death registration in 2844 Chinese counties in 2018 That means any national estimate built from registration data has to fill in large gaps, and different assumptions about those gaps produce different totals.
Second, the distinction between COVID-attributed deaths and all excess deaths matters. Some people died of heart attacks or strokes while hospitals were overwhelmed with COVID patients and could not provide timely care. Others may have had worsening chronic conditions that went untreated during the chaos of the wave. These deaths do not show up in a COVID-specific count but do appear in excess mortality estimates, which compare total deaths against the expected baseline. The studies producing higher numbers tend to be measuring all excess deaths; those producing lower numbers tend to be modeling COVID-specific mortality.
Third, one regional-comparison preprint estimated that excess deaths across China were over 1 million during each year of the pandemic, totaling over 4 million by the end of 2022.12medRxiv. Covid-19 Excess Mortality in China: A Regional Comparison That figure is much higher than other estimates and has not been peer-reviewed; it suggests substantial mortality even during the zero-COVID period, possibly from lockdown-related disruptions to healthcare access. Most other analyses focus on the exit wave and do not attempt to quantify earlier excess mortality in the same way, so this estimate occupies a somewhat separate conversation.
The Vaccination Gap in Older Adults
A crucial factor shaping the death toll was the state of vaccine coverage among the people most vulnerable to severe COVID. By summer 2022, the overall vaccination rate among Chinese adults 60 and older looked respectable: about 92% had received at least one dose, and roughly 89% had completed the primary series. But booster coverage told a different story, particularly among the oldest. Only about 47% of people aged 80 and older had received a booster shot, and just 72% had completed even the primary series.13Nature Medicine. Determinants of COVID-19 vaccination status and hesitancy among older adults in China Vaccination stagnated between the summer survey and the November 2022 policy shift, meaning these numbers essentially represent the level of protection in place when the wave hit.14PubMed Central. COVID-19 non-vaccination among older adults in China: a nationwide survey based on the China Health and Retirement Longitudinal Study (CHARLS)
This matters because inactivated-virus vaccines, which made up the vast majority of China’s vaccination campaign, required booster doses to provide meaningful protection against the Omicron variant. A study of hospitalized patients in China found that three or more doses of inactivated vaccine were about 74% effective against death and 65% effective against severe disease. The two most widely used vaccines, Sinopharm and Sinovac, showed comparable protection when boosted, at roughly 80% and 66% effectiveness against death respectively.15Journal of Infection and Public Health. Effectiveness of monovalent vaccines in preventing death and severe disease among Omicron-infected and hospitalized patients in China Data from Morocco’s Omicron wave similarly showed that a booster of Sinopharm’s vaccine was about 89% effective against COVID death overall.16PubMed Central. Effectiveness of Sinopharm’s BBIBP-CorV Booster Vaccination against COVID-19-Related Severe and Critical Cases and Deaths in Morocco during the Omicron Wave Three doses clearly helped. But with more than half of the over-80 population unboosted going into the exit wave, a large pool of the most vulnerable people faced the virus with diminished protection.
Hong Kong as a Preview
The closest real-world preview of what might happen in a population with low natural immunity and similar vaccines came from Hong Kong’s fifth wave in early 2022. When Omicron BA.2 swept through the territory, it caused over 1 million reported infections and more than 9,000 deaths within three months, with a crude case fatality rate of about 0.76%. The mortality burden fell overwhelmingly on unvaccinated elderly residents.17PubMed Central. Lessons learned from the fifth wave of COVID-19 in Hong Kong in early 2022 Hong Kong’s population of roughly 7.5 million is a tiny fraction of mainland China’s, but the pattern was instructive: in an immune-naive population using inactivated vaccines, Omicron could cause devastating mortality among unprotected older adults even though the variant was milder on average than earlier strains.
Scaling Hong Kong’s experience directly to the mainland is too simplistic because the populations differ in age structure, healthcare access, and density. But the Hong Kong wave demonstrated that the combination of Omicron, inactivated vaccines, and low elderly booster coverage was a recipe for high mortality. It was, in essence, the experiment that mainland China was about to run at a thousand times the scale.
The Role of Hospital Capacity
The sheer speed of China’s exit wave created an impossible burden on hospitals. When 84% of the population gets infected in a single month, even a low percentage of severe cases translates into staggering absolute numbers. China’s critical care bed capacity was limited relative to its population. An observational study of Asian countries found that middle-income economies had a median of about 6.6 critical care beds per 100,000 people, compared with about 13.9 in high-income economies.18The Lancet Regional Health – Western Pacific. Critical care bed capacity in Asian countries and regions before and during the COVID-19 pandemic: an observational study China’s specific numbers varied by region, but the overall picture was one where intensive care infrastructure could not absorb a sudden, nationwide surge.
Reports from Chinese hospitals during December 2022 and January 2023 described hallways lined with patients, oxygen shortages in smaller cities, and ambulance response times measured in hours rather than minutes. When a healthcare system is overwhelmed to that degree, people die not just from COVID itself but from all the other medical emergencies that cannot be treated in time. This is part of why excess mortality estimates consistently run higher than COVID-specific mortality models. The exit wave’s death toll was not just a virology problem; it was also a logistics catastrophe.
What the Pandemic Did to Life Expectancy
One way to gauge the overall impact is through life expectancy data, which captures mortality changes regardless of cause classification. A study of life expectancy across Asia found that the pandemic reduced life expectancy at birth in Asia by an average of 1.66 years between 2019 and 2021. South Asia lost about 3 years. But Eastern Asia, which includes China, showed almost no change during that same period.19PubMed Central. Impacts of the COVID-19 pandemic on life expectancy at birth in Asia That finding is consistent with zero-COVID having genuinely prevented mass mortality through 2021. The question is what happened to life expectancy after 2022, when the exit wave struck. Those data are slower to appear, and China has not published detailed national vital statistics covering the exit-wave period in a form that allows easy independent analysis.
The life expectancy picture reinforces an uncomfortable reality about the pandemic’s trajectory in China. For three years, the country’s strict containment policies almost certainly saved a large number of lives relative to what would have happened with uncontrolled spread. But those same policies left the population immunologically vulnerable, and when containment collapsed, the wave was among the fastest and deadliest exit events anywhere in the world. Whether zero-COVID ultimately saved more lives than it cost depends on a counterfactual that is impossible to resolve cleanly, and it is a question that remains politically sensitive within China.
Infection Fatality Rates and the Omicron Context
A global analysis of infection fatality rates found that the median weekly rate during the Omicron period was about 0.03%, roughly a third of the Delta-period median of 0.09%.20Frontiers in Public Health. A global analysis of COVID-19 infection fatality rate and its associated factors during the Delta and Omicron variant periods: an ecological study Omicron was genuinely less lethal per infection. But the same study found that infection rates during the Omicron period were more than four times higher than during Delta, and that the share of older people in a population and the prevalence of metabolic disorders were positively associated with fatality rates during Omicron. China checked both boxes: it has one of the world’s fastest-aging populations and high rates of conditions like diabetes and hypertension.
An infection fatality rate of even 0.1% applied to a billion infections produces a million deaths. At the scale of China’s exit wave, where the majority of 1.4 billion people were infected within weeks, even a modest fatality rate generates enormous absolute mortality. The arithmetic alone makes the official toll of roughly 121,000 hard to reconcile with what is known about the virus, the population, and the vaccine coverage. This is why independent researchers, using a half-dozen different methods and data sources, keep arriving at figures ten to fifteen times higher.
What China Has Not Released
The fundamental obstacle to a definitive answer is the absence of comprehensive, publicly available mortality data. China’s national death registration system exists, but its completeness varies dramatically by region, and the government has not published the kind of detailed, age-stratified, cause-of-death data that would allow outside researchers to calculate excess mortality directly. The Zhejiang cremation data appeared briefly online before being taken down. Several provinces reportedly stopped updating their vital statistics portals during the exit wave.
Without those data, researchers are left triangulating from cremation records, obituary search trends, elite death counts, and extrapolations from Hong Kong. Each of these methods has real limitations: cremation rates vary by region and custom, search data can be noisy, elite mortality may not mirror the general population’s, and Hong Kong’s demographics are not identical to the mainland’s. Yet the convergence of so many independent approaches on the same rough order of magnitude, around 1 to 2 million deaths from the exit wave, gives the estimate more weight than any single study would carry on its own. Epidemiologists will be refining these numbers for years as more data gradually surfaces, but the broad picture is unlikely to change.